Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary

  • Seunghyun Lee
  • , Namki Hong
  • , Gyu Seop Kim
  • , Jing Li
  • , Xiaoyu Lin
  • , Sarah Seager
  • , Sungjae Shin
  • , Kyoung Jin Kim
  • , Jae Hyun Bae
  • , Seng Chan You*
  • , Yumie Rhee*
  • , Sin Gon Kim
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Rare diseases occur in <50 per 100000 people and require lifelong management. However, essential epidemiological data on such diseases are lacking, and a consecutive monitoring system across time and regions remains to be established. Standardized digital phenotypes are required to leverage an international data network for research on rare endocrine diseases. We developed digital phenotypes for rare endocrine diseases using the observational medical outcome partnership common data model. Materials and Methods: Digital phenotypes of three rare endocrine diseases (medullary thyroid cancer, hypoparathyroidism, pheochromocytoma/paraganglioma) were validated across three databases that use different vocabularies: Severance Hospital’s electronic health record from South Korea; IQVIA’s United Kingdom (UK) database for general practitioners; and IQVIA’s United States (US) hospital database for general hospitals. We estimated the performance of different digital phenotyping methods based on International Classification of Diseases (ICD)-10 in the UK and the US or systematized nomenclature of medicine clinical terms (SNOMED CT) in Korea. Results: The positive predictive value of digital phenotyping was higher using SNOMED CT-based phenotyping than ICD-10-based phenotyping for all three diseases in Korea (e.g., pheochromocytoma/paraganglioma: ICD-10, 58%–62%; SNOMED CT, 89%). Estimated incidence rates by digital phenotyping were as follows: medullary thyroid cancer, 0.34–2.07 (Korea), 0.13–0.30 (US); hypoparathyroidism, 0.40–1.20 (Korea), 0.59–1.01 (US), 0.00–1.78 (UK); and pheochromocytoma/paraganglioma, 0.95–1.67 (Korea), 0.35–0.77 (US), 0.00–0.49 (UK). Conclusion: Our findings demonstrate the feasibility of developing digital phenotyping of rare endocrine diseases and highlight the importance of implementing SNOMED CT in routine clinical practice to provide granularity for research.

Original languageEnglish
Pages (from-to)187-194
Number of pages8
JournalYonsei medical journal
Volume66
Issue number3
DOIs
Publication statusPublished - 2025 Mar

Bibliographical note

Publisher Copyright:
© Yonsei University College of Medicine 2025.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Common data model
  • digital phenotyping
  • hypoparathyroidism
  • medullary thyroid cancer
  • pheochromocytoma
  • rare diseases

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Digital Phenotyping of Rare Endocrine Diseases Across International Data Networks and the Effect of Granularity of Original Vocabulary'. Together they form a unique fingerprint.

Cite this